Advanced Search

 

Study ID Status Title Patient Level Data
207597 Recruiting A randomized, double-blind, parallel group, multicenter, stratified study evaluating the efficacy and safety of repeat doses of GSK3772847 compared with placebo in participants with moderately severe asthma
207608 Not yet recruiting A Phase IV, 12-week, randomised, double-blind, triple dummy study to compare single inhaler triple therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) with multiple inhaler therapy (budesonide/formoterol plus tiotropium) based on lung function and symptoms in participants with chronic obstructive pulmonary disease
207609 Not yet recruiting A Phase IV, 12-week, randomised, double-blind, triple dummy study to compare single inhaler triple therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) with multiple inhaler therapy (budesonide/formoterol plus tiotropium) based on lung function and symptoms in participants with chronic obstructive pulmonary disease
207616 Compassionate use for subcutaneous (SC) Belimumab
207619 Completed A Clinical Study to Assess the Mildness of a Cosmetic Cleanser in Healthy Subjects Using the Forearm-Controlled Application Technique (FCAT)
207620 Not yet recruiting A cross-sectional study to characterize the prevalence of COPD and eosinophilia among primary care patients in Brazil
207625 Active, Not Recruiting Meta analysis to estimate the bacteriological treatment effect of nitrofurantoin for determination of the non-inferiority margin in uUTI
207626 Recruiting A Phase IV, 12 week, randomised, double-blind, double-dummy study to compare single inhaler triple therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), with tiotropium monotherapy based on lung function and symptoms in participants with chronic obstructive pulmonary disease
207640 Completed Determination of the Sun Protection Factor of a Cosmetic Daily Defence Skin Cream
207644 Completed Meta analysis of HPV-associated CIN2, CIN2+ and CIN3+ cases in efficacy studies according to baseline cytology and DNA status
207650 Completed Qualitative Research in Patients with Diabetic Foot Ulcer
207652 Recruiting Randomized, open label, 2-way crossover, single dose bioequivalence study of Paroxetine IR tablets manufactured in GSKT and Mississauga sites in healthy Chinese participants under fasting and fed conditions
207654 Completed An open label parallel group study to investigate the optimum methodology for the use of LPS or GM-CSF as challenge agents on healthy participants by assessing inflammatory biomarkers in cantharidin-induced skin blisters, peripheral blood, and urine
207656 Completed A Method Development Clinical Study Investigating the Efficacy of an Experimental Oral Rinse in Providing Long Term Relief from Dentinal Hypersensitivity
207660 Active, not recruiting A phase III study (a placebo controlled, randomized, double-blind comparative study and an open-label, uncontrolled study) to evaluate the efficacy and safety of GSK1358820 in patients with post-stroke upper limb spasticity
207674 Completed A randomised, double-blind, parallel group study to evaluate the safety, tolerability and pharmacokinetics of a single dose of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to healthy participants
207697 Not yet recruiting PGx7679: Exploratory Genetic Analysis for GSK2894512 for efficacy in psoriasis patients in 203120
207702 Recruiting A placebo-controlled, double-blind (sponsor open), randomized, crossover study to assess the efficacy, safety, and tolerability of GSK2798745 in participants with chronic cough
207727 Completed A single centre, single dose, open-label, randomised, 2-way crossover study in healthy Japanese male subjects to evaluate the bioequivalence of daprodustat tablets (2 mg tablet vs. 4 mg tablet) (Part 1) and the food effect on the pharmacokinetics of daprodustat (Part 2)
207733 Recruiting Use of diagnostic measures (including blood eosinophil counts) and their impact on lung specialists’ treatment decisions in patients with COPD in Germany
207734 Recruiting Post-Marketing Observational Study to Evaluate Safety Profile of Flixotide 50 μg pMDI Treatment in Chinese Subjects with Asthma aged 1-<4 years
207735 Recruiting BENLYSTA for intravenous injection / subcutaneous injection Special Drug Use Investigation
207754 Completed Qualitative research to explore patient preference for modes of administration in pulmonary arterial hypertension treatments
207757 Recruiting A long-term safety and efficacy follow-on study in participants with transfusion dependent beta-thalassemia who have previously received GSK2696277 (autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene) and completed the TIGET-BTHAL study
207759 Active, not recruiting An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of the investigational GSK Biologicals’ COPD vaccine (GSK3277511A) in adults

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.